Kaitlyn Kosko

DocwireNews

Patients with lung cancer can achieve a strong immune response against COVID-19 following full vaccination, according to a substudy of the SOLID trial. Furthermore, treatment type doesn&rsquo;t affect immune response.In the study, led by Mariano Provencio, MD, PhD, 1973 patients with stage IV disease (66.0%) who were receiving active treatment (82.7%) in 37 Spanish hospitals from March 3, 2021, to September 30, 2021, were assessed for serum anti-SARS-CoV-2 IgG antibody levels two different times&mdash;2 weeks and 6 months&mdash;after they received the last dose. All patients enrolled were fully vaccinated.Findings showed no significant differences in the probability of being seronegative for anti-SARS-CoV-2 IgG antibodies after full vaccination between patients who were actively receiving treatment and those who were not.Two weeks after vaccination, high levels of antibody titers were observed in 93.6% of the 1405 patients who received the second dose. Ten patients (0.5%) contracted SARS&#8209;CoV&#8209;2 infection within a median of 19 days after full vaccination.At 6 months, patients with a performance status &sup3;2 and comorbidities had a higher chance of being seronegative after full COVID-19 vaccination. The probability was lower for patients who were receiving immunotherapy or oral targeted therapy or who received the mRNA-1273 COVID-19 vaccine, the authors concluded.

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Patients Fully Vaccinated Have a Strong Immune Response Against COVID-19

Lung Cancer

Patients with lung cancer can achieve a strong immune response against COVID-19 following full vaccination.

Patients Fully Vaccinated Have a Strong  Immune Response Against COVID-19

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe